XIFAXAN
These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN. XIFAXAN (rifaximin) tablets, for oral use Initial U.S. Approval: 2004 To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
c5e8e2fd-7087-4b78-9181-cc259c0be2f1
HUMAN PRESCRIPTION DRUG LABEL
Nov 15, 2023
Salix Pharmaceuticals, Inc.
DUNS: 793108036
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
rifaximin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
rifaximin
Product Details
FDA regulatory identification and product classification information